(Q73505906)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

title

A phase II trial of docetaxel in platinum pre-treated patients with advanced epithelial ovarian cancer: a Japanese cooperative study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

main subject

phase II clinical trial

1 reference

1 reference

1 reference

1 reference

N Katsumata

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

R Tsunematsu

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Tanaka

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

Y Terashima

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

S Ogita

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

H Hoshiai

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

I Kohno

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Hirabayashi

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

M Yakushiji

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

K Noda

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

T Taguchi

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

publication date

1 December 2000

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

volume

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

page(s)

1531-1536

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

Assembly of purified GDP-tubulin into microtubules induced by taxol and taxotere: reversibility, ligand stoichiometry, and competition

4 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Relationships between the structure of taxol analogs and their antimitotic activity

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Studies With RP 56976 (Taxotere): A Semisynthetic Analogue of Taxol

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Comparative in vitro cytotoxicity of taxol and Taxotere against cisplatin-sensitive and -resistant human ovarian carcinoma cell lines

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Defining response of ovarian carcinoma to initial chemotherapy according to serum CA 125

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Phase II trial of docetaxel in patients with platinum-refractory advanced ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Docetaxel: an active new drug for treatment of advanced epithelial ovarian cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Phase II trials of docetaxel (Taxotere) in advanced ovarian cancer--an updated overview

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Second-line platinum therapy in patients with ovarian cancer previously treated with cisplatin

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Phase II trial of oral altretamine for relapsed ovarian carcinoma: evaluation of defining response by serum CA125

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

Corticosteroids significantly delay the onset of docetaxel-induced fluid retention: final results of a randomized study of the European Organization for Research and Treatment of Cancer Investigational Drug Branch for Breast Cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1008337103708

1 reference

7 January 2021

Identifiers

DOI

10.1023/A:1008337103708

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11205459%20AND%20SRC:MED&resulttype=core&format=json

4 November 2019

1 reference